Stroke survivors take an average of 11 medications a day,
researchers note in JAMA Neurology. Half of stroke survivors under
age 65 spend at least 10 percent of their disposable income on
health care, and these middle-aged people are more likely to be
uninsured than older people who qualify for Medicare.
The new study focused on four periods: 2000 to 2005 as a historical
control group; 2006 to 2010 during an economic recession and peak
unemployment; 2011 to 2013 before ACA implementation; and 2014 to
2016 after ACA implementation.
The proportion of stroke survivors who didn't take medications as
prescribed due to cost rose steadily during the first three periods,
from about 19 percent to almost 24 percent. However, after the ACA
was implemented, that proportion fell to 18 percent.
"It was harder for younger stroke survivors to afford medications
before the ACA because many were uninsured," said study leader Dr.
Deborah Levine of the University of Michigan Medical School in Ann
Arbor. "After implementation of the Affordable Care Act, health
insurance coverage, namely Medicaid, increased and skipping
medications due to cost decreased among younger stroke survivors."
From the period right before ACA implementation, 2011 to 2013, to
the period after the law took effect, the proportion of stroke
survivors receiving Medicaid benefits rose from 24 percent to almost
31 percent as many states made Medicaid available to adults who
might not have qualified in the past.
Even after researchers accounted for health insurance, the ACA
implementation was still associated with 24 percent lower odds that
people would fail to take prescribed medicines.
Stroke survivors who skip or delay refilling medications or who take
smaller than prescribed doses are at risk for another stroke, Levine
said by email.
"Repeat strokes are more deadly, disabling, and costly than first
strokes," Levine said. "Stroke survivors who skip medications due to
cost are more likely to have uncontrolled blood pressure, diabetes,
and cholesterol that in turn increase their risk for stroke."
The 13,930 stroke survivors in the study were 56 years old on
average, ranging in age from 45 to 64.
[to top of second column] |
The study wasn't a controlled experiment designed to prove whether
or how the ACA directly influenced medication compliance among
younger stroke survivors. Researchers also relied on study
participants to report any history of stroke, and this wasn't
verified with medical records.
Still, the results offer fresh evidence of the potential for
expanded Medicaid coverage under the ACA to reduce hospitalizations
of uninsured people for strokes and other major cardiovascular
problems, said Dr. Joseph Ross, a professor of medicine and public
health at Yale University in New Haven, Connecticut, who wasn't
involved in the study.
"It is no surprise, but reassuring to see, that after the ACA was
enacted and Medicaid expanded in many states, that rates of
uninsured hospitalizations declined among stroke survivors, as did
rates of cost-related non-adherence as patients now had insurance,
enabling them to afford the costs of the medications prescribed
after their stroke," Ross said by email.
Before the ACA, people without insurance who had a stroke or other
major health event would likely be uninsurable afterward because of
their pre-existing conditions, said Stacie Dusetzina, a researcher
at Vanderbilt University School of Medicine in Nashville, Tennessee,
who wasn't involved in the study.
"Those individuals . . . would likely have a large number of
medications prescribed to them to prevent subsequent strokes or
treat other conditions, and they would likely have to pay
out-of-pocket for the full price of those medications," Dusetzina
said by email. "Alternatively, if individuals were able to access
Medicaid after the ACA they could have new access to medications at
very low out-of-pocket prices."
SOURCE: http://bit.ly/2MZGeW8 JAMA Neurology, online August 27,
2018.
[© 2018 Thomson Reuters. All rights
reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |